Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients,A double-blind clinical trial with placebo
Phase 3
Recruiting
- Conditions
- Drug-induced polyneuropathy.Drug-induced polyneuropathyG62.0
- Registration Number
- IRCT20240314061286N1
- Lead Sponsor
- Gorgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 141
Inclusion Criteria
Age over 18 years and under 80 years
Cancer patients based on the diagnosis of the physician and the pathology sample
Willingness and consent to participate in the study
Do not use drugs that affect serotonin levels
Do not use painkillers and drugs effective on neuropathic pain routinely from two weeks before starting duloxetine or venlafaxine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method